Welcome to our dedicated page for HERSHEY CO SEC filings (Ticker: HSY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hershey Company's SEC filings document formal disclosures for its snacks business, public-company governance and capital structure. Recent 8-K reports furnish quarterly and annual sales and earnings releases, financial outlook updates, investor day materials and Regulation FD presentations tied to the company's confectionery, salty-snack and functional-snacking portfolio.
Proxy and governance filings cover director elections, auditor ratification, executive compensation, stockholder voting by Common Stock and Class B Common Stock, and amendments to the company's by-laws. Other current reports record leadership changes, financial-statement exhibits and Inline XBRL cover-page data associated with material events.
Deirdre Mahlan, a Director of The Hershey Company (HSY), reported an acquisition of 225.07 shares of the issuer's common stock on 10/01/2025 under a Section 16 Form 4 filing. The shares were acquired at a reported price of $0, and the report shows 623.922 shares beneficially owned by the reporting person following the transaction. The filing notes that 2.923 of the shares included in the total were acquired on 09/15/2025 through the company’s directors’ dividend reinvestment feature. The Form 4 was signed by an agent on 10/03/2025.
Hershey (HSY): Director Barry J. Nalebuff reported acquiring 225.07 shares of common stock on 10/01/2025 at a reported price of $0 per share. Following this transaction, he directly owns 860.386 shares.
The filing notes that the reported direct holdings include 2.923 shares acquired on 09/15/2025 through a dividend reinvestment feature of the Company’s Directors’ Compensation Plan.
Maria T. Kraus, a Director of The Hershey Company (HSY), reported a purchase of 225.07 shares on 10/01/2025. After this transaction she beneficially owns 2,394.493 shares directly. The filing itemizes the acquisition as a non-derivative purchase with a reported price of $0 for the shares and includes an explanatory note that 7.213 of the directly owned shares were previously acquired on 9/15/2025 through the Company’s directors' dividend reinvestment feature. The Form 4 was signed by an agent on 10/03/2025.
Cordel Robbin-Coker, a Hershey Co. (HSY) director, reported acquiring 225.07 shares of Hershey common stock on 10/01/2025 under a non‑derivative transaction coded as an acquisition. The reported price is $0, consistent with shares obtained through a company plan rather than an open‑market purchase, leaving the reporting person with 1,587.67 shares beneficially owned following the transaction. The filing notes an earlier dividend reinvestment on 9/15/2025 that added 7.213 shares under the Company’s Directors' Compensation Plan. The form is signed by an agent on 10/03/2025.
Hershey Co. director Kevin M. Ozan reported an acquisition of company common stock on 10/01/2025. The filing discloses an A (acquisition) transaction of 225.07 shares at a reported price of $0, bringing his direct beneficial ownership to 1,590.464 shares. The form notes that the direct ownership total includes 10.007 shares acquired on 09/15/2025 through a dividend reinvestment feature of the Company’s Directors' Compensation Plan, which the filing says is substantially similar to the broad-based plan for stockholders. The Form 4 was submitted by an agent and signed on 10/03/2025.
Marie Quintero-Johnson, a director of The Hershey Company (HSY), reported an acquisition of 225.07 shares of Common Stock on 10/01/2025 under a Section 16 Form 4. The reported transaction price is $0, and following the transaction she beneficially owns 623.922 shares. The filing notes that 2.923 of the shares included in her direct ownership were acquired on 9/15/2025 through the Company’s dividend reinvestment feature for directors, which mirrors the broad-based plan available to stockholders.
The filing shows that director Mary Kay Haben (address listed) reported an acquisition of 225.07 shares of HERSHEY CO (HSY) on 10/01/2025 at a reported price of $0. After the transaction, she beneficially owned 16,945.894 shares. The filing notes that 122.546 of the directly owned shares were acquired earlier on 09/15/2025 through a dividend reinvestment feature of the Company’s Directors' Compensation Plan. The Form 4 was signed by an agent on behalf of the reporting person on 10/03/2025.
Harold Singleton III, a Director of The Hershey Company (HSY), reported acquiring 225.07 shares of Hershey common stock on 10/01/2025 at a reported price of $0. After the transaction, he beneficially owns 623.922 shares, held directly. The filing notes that 2.923 of the reported shares were acquired on 9/15/2025 under the Company’s directors' dividend reinvestment feature, which mirrors the broad-based plan available to shareholders. The Form 4 was signed by an agent on 10/03/2025.
Steven E. Voskuil, identified as an officer (SVP, Chief Financial Officer) of Hershey Co. (HSY), reported a sale of 1,500 shares of Hershey common stock on 09/18/2025 at a price of $189.12 per share. After the transaction he beneficially owned 58,319 shares, held directly. The filing states the sale was effected under a Rule 10b5-1 trading plan adopted on May 20, 2025, indicating the transaction followed a pre-established plan rather than an ad hoc decision. The Form 4 was signed by an agent on behalf of the reporting person.
Hershey Co. (HSY) Rule 144 notice reports a proposed sale of 1,500 common shares via Fidelity Brokerage, scheduled for 09/18/2025, with an aggregate market value of $283,680 and 148,110,715 shares outstanding. The shares were acquired on 02/21/2024 through restricted stock vesting and were granted as compensation. The filer disclosed two prior open-market sales in the past three months: 5,000 shares sold 07/21/2025 for $900,000 and 1,500 shares sold 08/18/2025 for $267,795. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information.